GREENLAND MINES LTD Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
GREENLAND MINES LTD (GRML) reported Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $6.90 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-17.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2024-04-17
- GREENLAND MINES LTD adjustments to additional paid in capital, stock issued, issuance costs for the quarter ending 2022-06-30 was $6.90M.
- GREENLAND MINES LTD adjustments to additional paid in capital, stock issued, issuance costs for fiscal 2022 was $6.90M.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 3 month | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 12 month |
|---|---|---|
| 2022-12-31 | $6.90M 10-K · filed 2024-04-17 | |
| 2022-06-30 | $6.90M 10-Q · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |